Interojo Co

Interojo Co Total Assets

The Total Assets of Interojo Co (119610.KQ) as of Oct 21, 2026 is 244.89 B KRW. In the previous year, Total Assets was 234.40 B KRW — a change of 4.48% (higher).

Total Assets

244.89 BKRW

YoY

4.48%

Last updated:

Total Assets of Interojo Co is 2025 244.89 B KRW. Total Assets of Interojo Co was 2024 234.40 B KRW. It decreases by 4.48% higher compared to the previous year.

The Interojo Co Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
146.04 B KRW
Jan 1, 2019
181.12 B KRW
Jan 1, 2020
194.16 B KRW
Jan 1, 2021
231.95 B KRW
Jan 1, 2022
263.77 B KRW
Jan 1, 2023
278.76 B KRW
Jan 1, 2024
234.40 B KRW
Jan 1, 2025
244.89 B KRW
The Interojo Co Total Assets history
YEARTotal AssetsYoY
244.89 BKRW+4.48%
234.40 BKRW-15.91%
278.76 BKRW+5.69%
263.77 BKRW+13.72%
231.95 BKRW+19.46%
194.16 BKRW+7.20%
181.12 BKRW+24.02%
146.04 BKRW+21.16%
120.53 BKRW+12.66%
106.99 BKRW+15.47%
92.65 BKRW+22.17%
75.84 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Interojo Co Stock analysis

What does Interojo Co do? Interojo Co Ltd manufactures and sells contact lenses including silicone hydrogel lenses, sodium hyaluronate lenses, frequent replacement lenses, conventional lenses, toric lenses, multifocal vision lenses, color lenses, therapy and bandage lenses, and rigid gas permeable (RGP) contact lenses along with solutions. The company distributes its products in domestic and overseas markets, targeting both retail consumers and healthcare providers who purchase lenses for patient use. Its product range caters to diverse vision correction needs, from standard to specialized medical applications, with solutions supporting lens care and usage. The firm's primary revenue streams come from the sale of contact lenses and associated solutions to customers in both domestic and international markets. Products like silicone hydrogel lenses and RGP contact lenses represent key offerings for everyday wear and specialized vision correction, while therapy and bandage lenses serve medical applications requiring professional oversight. The company's domestic market presence complements its overseas distribution, ensuring broad accessibility across different customer segments. Interojo Co Ltd's business model focuses on direct sales of its comprehensive product portfolio to end-users and healthcare institutions. The company's product lines address various vision correction scenarios, from routine daily use with frequent replacement lenses to advanced medical needs with therapy lenses. By maintaining a diverse range of contact lenses and solutions, the company serves both consumer and professional markets without relying on third-party partnerships or additional services. Interojo Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Interojo Co stock

Total Assets of Interojo Co is 244.89 B KRW in 2025.

Total Assets of Interojo Co changed from 234.40 B KRW to 244.89 B KRW, representing a 4.48% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Interojo Co since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Interojo Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Interojo Co

All Key Metrics — Interojo Co